Brief: Vaxcyte Announces FDA Clearance of Investigational New Drug Application for VAX-31
19/10/2023 13:48
Oct 19 (Reuters) - Vaxcyte Inc PCVX.O :
* VAXCYTE ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW
DRUG
APPLICATION FOR VAX-31 FOR THE PREVENTION OF INVASIVE
PNEUMOCOCCAL DISEASE IN ADULTS
* VAXCYTE INC - TOPLINE SAFETY, TOLERABILITY AND
IMMUNOGENICITY
RESULTS FROM VAX-31 PHASE 1/2 STUDY EXPECTED IN SECOND HALF OF
2024
* VAXCYTE INC: EXPECTS TO INITIATE VAX-31 PHASE 1/2 STUDY IN
HEALTHY ADULTS THIS QUARTER
Source text for Eikon: ID:nGNX8JP8NZ
Further company coverage: PCVX.O
((Reuters.Briefs@thomsonreuters.com;))